Đang chuẩn bị liên kết để tải về tài liệu:
INFECTIOUS DISEASES - PART 8

Những cá nhân này sẽ nhận được Td thay vì của Tdap. Biện pháp phòng ngừa hành chính của Tdap, Td, hoặc cả hai vắc-xin. Đề phòng là một điều kiện người nhận có thể làm tăng nguy cơ của một phản ứng nghiêm trọng. Trong những tình huống này, các chuyên gia chăm sóc sức khỏe nên đánh giá rủi ro và lợi ích của việc quản lý thuốc chủng ngừa | identifiable cause. These individuals should receive Td instead of Tdap. Precautions to Administration of Tdap Td or Both Vaccines. A precaution is a condition in a recipient that might increase risk of a serious reaction. In these situations health care professionals should evaluate the risks and benefits of administering Tdap or Td vaccine. Precautions include the following Guillain-Barre syndrome GBS 6 weeks or less after the previous dose of a tetanus toxoid vaccine. If a decision is made to continue tetanus toxoid immunization Tdap vaccine is preferred if otherwise indicated. Progressive neurologic disorder uncontrolled epilepsy or progressive encephalopathy until the condition has stabilized. This precaution is for vaccines with pertussis components. If a decision is made to withhold pertussis immunization Td may be used instead of Tdap vaccine. This condition is a contraindication for use of DTaP vaccine in children. Deferral of Administration of Tdap Td or Both Vaccines. Reasons for deferral include the following Moderate or severe acute illness with or without fever. Immunization should be deferred until the acute illness resolves. History of a severe Arthus hypersensitivity reaction after a previous dose of a tetanus and diphtheria toxoid-containing vaccine or a diphtheria toxoid vaccine that does not contain tetanus toxoid such as MCV4 which contains diphtheria toxoid as a carrier protein . If a true Arthus reaction is likely vaccine providers should defer Tdap or Td immunization for at least 10 years after the tetanus or diphtheria toxoid-containing vaccine. If the Arthus reaction was associated with a vaccine that contained diphtheria toxoid without tetanus toxoid eg MCV4 deferring Tdap or Td vaccine that might leave the adolescent inadequately protected against tetanus. In this situation if the last tetanus toxoid vaccine was administered 10 years or more earlier providers may administer TT vaccine or consider measuring tetanus antibody concentrations